SE8901889D0 - Novel 8-substituted-2-aminotetralines - Google Patents

Novel 8-substituted-2-aminotetralines

Info

Publication number
SE8901889D0
SE8901889D0 SE8901889A SE8901889A SE8901889D0 SE 8901889 D0 SE8901889 D0 SE 8901889D0 SE 8901889 A SE8901889 A SE 8901889A SE 8901889 A SE8901889 A SE 8901889A SE 8901889 D0 SE8901889 D0 SE 8901889D0
Authority
SE
Sweden
Prior art keywords
substituted
hydrogen
compounds
fused
alkyl
Prior art date
Application number
SE8901889A
Other languages
English (en)
Swedish (sv)
Inventor
N N-E And
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE8901889A priority Critical patent/SE8901889D0/xx
Publication of SE8901889D0 publication Critical patent/SE8901889D0/xx
Priority to IL9442890A priority patent/IL94428A/en
Priority to ZA903801A priority patent/ZA903801B/xx
Priority to NZ233724A priority patent/NZ233724A/xx
Priority to IE183390A priority patent/IE75057B1/en
Priority to AT90850209T priority patent/ATE129696T1/de
Priority to YU100690A priority patent/YU48830B/sh
Priority to PCT/SE1990/000351 priority patent/WO1990014330A1/en
Priority to AU58185/90A priority patent/AU644081B2/en
Priority to MX2084290A priority patent/MX20842A/es
Priority to SU904894777A priority patent/RU2093507C1/ru
Priority to UA4894777A priority patent/UA40562C2/uk
Priority to HU904810A priority patent/HUT58685A/hu
Priority to JP2508698A priority patent/JP2818692B2/ja
Priority to CA002032498A priority patent/CA2032498C/en
Priority to KR1019910700092A priority patent/KR100193981B1/ko
Priority to SI9011006A priority patent/SI9011006B/sl
Priority to EP90850209A priority patent/EP0399982B1/en
Priority to DK90850209.9T priority patent/DK0399982T3/da
Priority to DE69023274T priority patent/DE69023274T2/de
Priority to ES90850209T priority patent/ES2078962T3/es
Priority to IS3580A priority patent/IS1663B/is
Priority to DZ900088A priority patent/DZ1417A1/fr
Priority to PL90285330A priority patent/PL165166B1/pl
Priority to PL90300984A priority patent/PL164245B1/pl
Priority to SK2560-90A priority patent/SK280731B6/sk
Priority to PH40567A priority patent/PH31110A/en
Priority to CS902560A priority patent/CZ286038B6/cs
Priority to DD90340992A priority patent/DD298909A5/de
Priority to PT94163A priority patent/PT94163B/pt
Priority to JO19901617A priority patent/JO1617B1/en
Priority to CN90103956A priority patent/CN1023399C/zh
Priority to SA90100274A priority patent/SA90100274B1/ar
Priority to NO910310A priority patent/NO176603C/no
Priority to FI910381A priority patent/FI114151B/fi
Priority to HRP-1006/90A priority patent/HRP920622B1/xx
Priority to US08/033,013 priority patent/US5635537A/en
Priority to LVP-93-869A priority patent/LV10243B/xx
Priority to LTIP1723A priority patent/LT3966B/lt
Priority to HU95P/P00719P priority patent/HU211880A9/hu
Priority to GR950403703T priority patent/GR3018566T3/el
Priority to LVP-96-420A priority patent/LV11736B/en
Priority to HK55697A priority patent/HK55697A/en
Priority to CY198997A priority patent/CY1989A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Polyamides (AREA)
SE8901889A 1989-05-26 1989-05-26 Novel 8-substituted-2-aminotetralines SE8901889D0 (sv)

Priority Applications (44)

Application Number Priority Date Filing Date Title
SE8901889A SE8901889D0 (sv) 1989-05-26 1989-05-26 Novel 8-substituted-2-aminotetralines
IL9442890A IL94428A (en) 1989-05-26 1990-05-17 2-Aminutterlins 8-Transformed, a process for their preparation and preparations that quench them
ZA903801A ZA903801B (en) 1989-05-26 1990-05-17 Novel-8-substituted-2-aminotetralines
NZ233724A NZ233724A (en) 1989-05-26 1990-05-18 8-substituted-2-aminotetralin derivatives; preparatory processes and pharmaceutical compositions
IE183390A IE75057B1 (en) 1989-05-26 1990-05-22 Novel 8-substituted-2-amino-tetralines
CA002032498A CA2032498C (en) 1989-05-26 1990-05-23 Novel 8-substituted-2-aminotetralines
ES90850209T ES2078962T3 (es) 1989-05-26 1990-05-23 Nuevas 8-sustituidas-2-amino-tetralinas.
DZ900088A DZ1417A1 (fr) 1989-05-26 1990-05-23 Composés nouveaux 8-substitués-2-aminotétraline.
PCT/SE1990/000351 WO1990014330A1 (en) 1989-05-26 1990-05-23 Novel 8-substituted-2-aminotetralines
AU58185/90A AU644081B2 (en) 1989-05-26 1990-05-23 Novel 8-substituted-2-aminotetralines
MX2084290A MX20842A (es) 1989-05-26 1990-05-23 Proceso para la preparacion de nuevas 2-aminotetralinas substituidas y compuesto obtenido.
SU904894777A RU2093507C1 (ru) 1989-05-26 1990-05-23 8-замещенные-2-аминотетралиновые производные и способы из получения
UA4894777A UA40562C2 (uk) 1989-05-26 1990-05-23 1,8-заміщені-2-амінотетралінові похідні або їх енантіомери і фізіологічно прийнятні солі та спосіб їх одержання (варіанти)
HU904810A HUT58685A (en) 1989-05-26 1990-05-23 Process for producing new 8-substituted 2-amino-tetralines and pharmaceutical compositiions containing them
JP2508698A JP2818692B2 (ja) 1989-05-26 1990-05-23 新規な８―置換―２―アミノテトラリン類
YU100690A YU48830B (sh) 1989-05-26 1990-05-23 Novi 8-supstituisani-2-aminotetralini
KR1019910700092A KR100193981B1 (ko) 1989-05-26 1990-05-23 신규한 8-치환-2-아미노테트랄린
SI9011006A SI9011006B (sl) 1989-05-26 1990-05-23 Novi 8-substituirani-2-aminotetralini
EP90850209A EP0399982B1 (en) 1989-05-26 1990-05-23 Novel 8-substituted-2-amino-tetralines
DK90850209.9T DK0399982T3 (da) 1989-05-26 1990-05-23 Hidtil ukendte 8-substituerede-2-amino-tetraliner
DE69023274T DE69023274T2 (de) 1989-05-26 1990-05-23 8-Substituierte-2-Aminotetraline.
AT90850209T ATE129696T1 (de) 1989-05-26 1990-05-23 8-substituierte-2-aminotetraline.
IS3580A IS1663B (is) 1989-05-26 1990-05-23 Ný 8-súbstitúeruð-2-amínótetralín
PL90300984A PL164245B1 (pl) 1989-05-26 1990-05-24 Sposób wytwarzania nowych pochodnych 2-amlnotetraliny PL PL PL PL PL
PL90285330A PL165166B1 (pl) 1989-05-26 1990-05-24 Sposób wytwarzania nowych pochodnych 2 -aminotetraliny PL PL PL PL PL
SK2560-90A SK280731B6 (sk) 1989-05-26 1990-05-25 8-substituované 2-aminotetralíny, spôsob ich výrob
PH40567A PH31110A (en) 1989-05-26 1990-05-25 8-Substituted-2-aminotetralins.
PT94163A PT94163B (pt) 1989-05-26 1990-05-25 Processo para a preparacao de novas 2-aminotetralinas 8-substituidas e de composicoes farmaceuticas que as contem
CS902560A CZ286038B6 (cs) 1989-05-26 1990-05-25 Derivát v poloze 8-substituovaného 2-aminotetralinu, způsoby jeho přípravy, farmaceutický prostředek s jeho obsahem a použití
DD90340992A DD298909A5 (de) 1989-05-26 1990-05-25 Verfahren zur herstellung 8-substituierter 2-aminotetraline
JO19901617A JO1617B1 (en) 1989-05-26 1990-05-26 Modern 2-amino-tetraline-8 compounds
CN90103956A CN1023399C (zh) 1989-05-26 1990-05-26 制备新的8-取代的2-氨基-1，2，3，4-四氢化萘类化合物的方法
SA90100274A SA90100274B1 (ar) 1989-05-26 1990-06-09 مركبات 8- مستبدلة-2- امينيوتترالينات حديثة 8- substituted-2- aminotealines
NO910310A NO176603C (no) 1989-05-26 1991-01-25 Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive 8-substituert-2-aminotetraliner
FI910381A FI114151B (fi) 1989-05-26 1991-01-25 Menetelmä terapeuttisesti aktiivisen 2-aminotetraliiniyhdisteen valmistamiseksi
HRP-1006/90A HRP920622B1 (en) 1989-05-26 1992-09-30 Novel 8-substituted-2-amino-tetralines
US08/033,013 US5635537A (en) 1989-05-26 1993-03-18 8-substituted-2-aminotetralins
LVP-93-869A LV10243B (en) 1989-05-26 1993-06-30 Novel 8-substituted-2-aminotetralines
LTIP1723A LT3966B (en) 1989-05-26 1993-12-30 Novel 8-substituted-2-aminotetralines, process for preparing thereof, pharmaceutical composition
HU95P/P00719P HU211880A9 (en) 1989-05-26 1995-06-30 Novel 8-substituted-2-aminotetralines
GR950403703T GR3018566T3 (en) 1989-05-26 1995-12-29 Novel 8-substituted-2-amino-tetralines.
LVP-96-420A LV11736B (en) 1989-05-26 1996-11-01 Novel 8-substituted-2-amino-tetralines
HK55697A HK55697A (en) 1989-05-26 1997-05-01 Novel 8-substituted-2-amino-tetralines
CY198997A CY1989A (en) 1989-05-26 1997-09-05 Novel 8-substituted-2-amino-tetralines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8901889A SE8901889D0 (sv) 1989-05-26 1989-05-26 Novel 8-substituted-2-aminotetralines

Publications (1)

Publication Number Publication Date
SE8901889D0 true SE8901889D0 (sv) 1989-05-26

Family

ID=20376074

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901889A SE8901889D0 (sv) 1989-05-26 1989-05-26 Novel 8-substituted-2-aminotetralines

Country Status (41)

Country Link
US (1) US5635537A (cs)
EP (1) EP0399982B1 (cs)
JP (1) JP2818692B2 (cs)
KR (1) KR100193981B1 (cs)
CN (1) CN1023399C (cs)
AT (1) ATE129696T1 (cs)
AU (1) AU644081B2 (cs)
CA (1) CA2032498C (cs)
CY (1) CY1989A (cs)
CZ (1) CZ286038B6 (cs)
DD (1) DD298909A5 (cs)
DE (1) DE69023274T2 (cs)
DK (1) DK0399982T3 (cs)
DZ (1) DZ1417A1 (cs)
ES (1) ES2078962T3 (cs)
FI (1) FI114151B (cs)
GR (1) GR3018566T3 (cs)
HK (1) HK55697A (cs)
HR (1) HRP920622B1 (cs)
HU (2) HUT58685A (cs)
IE (1) IE75057B1 (cs)
IL (1) IL94428A (cs)
IS (1) IS1663B (cs)
JO (1) JO1617B1 (cs)
LT (1) LT3966B (cs)
LV (2) LV10243B (cs)
MX (1) MX20842A (cs)
NO (1) NO176603C (cs)
NZ (1) NZ233724A (cs)
PH (1) PH31110A (cs)
PL (2) PL165166B1 (cs)
PT (1) PT94163B (cs)
RU (1) RU2093507C1 (cs)
SA (1) SA90100274B1 (cs)
SE (1) SE8901889D0 (cs)
SI (1) SI9011006B (cs)
SK (1) SK280731B6 (cs)
UA (1) UA40562C2 (cs)
WO (1) WO1990014330A1 (cs)
YU (1) YU48830B (cs)
ZA (1) ZA903801B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2123500T3 (es) 1989-05-31 1999-01-16 Upjohn Co Derivados de 8-heterociclil-2-aminotetralina activos sobre el sistema nervioso central.
CA2048846A1 (en) * 1990-08-15 1992-02-16 Craig Steven Hoechstetter Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and aminothiochromanes
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
DE69218813T2 (de) * 1991-02-08 1997-08-14 Lilly Co Eli Ringsubstituierte 2-Amino-1,2,3,4-tetrahydronaphthaline
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5641794A (en) * 1991-03-28 1997-06-24 Eli Lilly Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
AU1106195A (en) * 1994-11-09 1996-06-06 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
GB9509156D0 (en) * 1995-05-05 1995-06-28 Sandoz Ltd Organic compounds
CA2591937C (en) * 2004-12-21 2013-08-06 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN101111472A (zh) * 2004-12-21 2008-01-23 弗·哈夫曼-拉罗切有限公司 1,2,3,4-四氢化萘和茚满衍生物及其作为5-ht拮抗剂的用途
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
BR112023017490A2 (pt) 2021-03-17 2023-11-07 Receptos Llc Métodos de tratamento de dermatite atópica com anticorpos anti il-13

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4247907A (en) * 1978-11-27 1981-01-27 International Business Machines Corporation Method and apparatus for typing characters and optically readable binary representations thereof on same page
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
DE3479314D1 (en) * 1984-05-22 1989-09-14 Nelson Res & Dev Substituted 2-aminotetralins and processes for synthesis
EP0209275B1 (en) * 1985-06-26 1988-10-19 Smithkline Beckman Corporation Benz-trisubstituted 2-aminotetralins
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
DE69013672T2 (de) * 1989-01-09 1995-03-30 Upjohn Co Halogensubstituierte aminotetraline.
ES2123500T3 (es) * 1989-05-31 1999-01-16 Upjohn Co Derivados de 8-heterociclil-2-aminotetralina activos sobre el sistema nervioso central.

Also Published As

Publication number Publication date
CY1989A (en) 1997-09-05
IE75057B1 (en) 1997-08-27
EP0399982A1 (en) 1990-11-28
HRP920622B1 (en) 2000-04-30
HRP920622A2 (en) 1998-06-30
PL165166B1 (pl) 1994-11-30
AU644081B2 (en) 1993-12-02
MX20842A (es) 1993-11-01
UA40562C2 (uk) 2001-08-15
SK256090A3 (en) 2000-07-11
LV11736B (en) 1997-10-20
FI114151B (fi) 2004-08-31
CA2032498C (en) 2002-03-26
KR920701121A (ko) 1992-08-11
IS1663B (is) 1997-07-04
SA90100274B1 (ar) 2005-06-01
SI9011006A (en) 1997-12-31
PL285330A1 (en) 1991-11-04
WO1990014330A1 (en) 1990-11-29
SI9011006B (sl) 1998-12-31
GR3018566T3 (en) 1996-03-31
DD298909A5 (de) 1992-03-19
ZA903801B (en) 1991-01-30
LV10243A (lv) 1994-10-20
DZ1417A1 (fr) 2004-09-13
NO910310D0 (no) 1991-01-25
ES2078962T3 (es) 1996-01-01
HUT58685A (en) 1992-03-30
RU2093507C1 (ru) 1997-10-20
IL94428A0 (en) 1991-03-10
US5635537A (en) 1997-06-03
LV10243B (en) 1995-04-20
YU48830B (sh) 2002-03-18
EP0399982B1 (en) 1995-11-02
HU211880A9 (en) 1995-12-28
CN1023399C (zh) 1994-01-05
SK280731B6 (sk) 2000-07-11
AU5818590A (en) 1990-12-18
LV11736A (lv) 1997-04-20
NZ233724A (en) 1993-01-27
DE69023274T2 (de) 1996-04-11
CZ286038B6 (cs) 1999-12-15
HK55697A (en) 1997-05-09
NO910310L (no) 1991-01-25
LT3966B (en) 1996-05-27
PL164245B1 (pl) 1994-07-29
LTIP1723A (en) 1995-08-25
IS3580A7 (is) 1990-11-27
DK0399982T3 (da) 1996-03-04
ATE129696T1 (de) 1995-11-15
JPH04500362A (ja) 1992-01-23
NO176603B (no) 1995-01-23
PT94163A (pt) 1991-01-08
KR100193981B1 (ko) 1999-06-15
CA2032498A1 (en) 1990-11-27
YU100690A (en) 1992-05-28
CN1047494A (zh) 1990-12-05
FI910381A0 (fi) 1991-01-25
IL94428A (en) 1995-12-31
HU904810D0 (en) 1991-06-28
CZ256090A3 (cs) 1999-10-13
JO1617B1 (en) 1991-11-27
PH31110A (en) 1998-02-23
PT94163B (pt) 1996-12-31
DE69023274D1 (de) 1995-12-07
IE901833L (en) 1990-11-26
NO176603C (no) 1995-05-03
JP2818692B2 (ja) 1998-10-30

Similar Documents

Publication Publication Date Title
KR920701121A (ko) 신규한 8-치환-2-아미노테트랄린
FI893751A0 (fi) Kemiska foereningar.
SE8605504D0 (sv) Novel chroman derivatives
DK231586D0 (da) Oxadiazolylimidazobenzodiazepinforbindelse, farmaceutisk praeparat indeholdende samme, fremgangsmaade til fremstilling af forbindelsen og fremgangsmaade til behandling af en centralnervesystemsygdom
DK143483D0 (da) Fremgangsmade til fremstilling af enantiomerer af substituerede fenylazacykloalkaner
DK162188D0 (da) Fremgangsmaade til fremstilling af pentandionderivater
DK601883A (da) Phenyl-propanolderivater